论文部分内容阅读
目的观察灯盏花素联合银杏制剂治疗脑卒中后遗症的效果。方法 72例脑卒中患者随机分为两组(对照组和治疗组),对照组给予银杏制剂治疗,治疗组采用灯盏花素联合银杏制剂治疗。结果治疗组的总有效率高于对照组(P<0.05),与对照组比较,治疗组MQ增值明显,差异有统计学意义(P<0.05)。治疗期间,患者未发生严重不良反应。结论银杏制剂和灯盏花素具有协同作用,两者联合治疗脑卒中后遗症疗效显著,安全可靠,可推广应用。
Objective To observe the effect of Breviscapine combined with Ginkgo biloba in the treatment of stroke sequelae. Methods 72 stroke patients were randomly divided into two groups (control group and treatment group). The control group received Ginkgo biloba preparation. The treatment group was treated with breviscapine and ginkgo biloba preparation. Results The total effective rate in the treatment group was higher than that in the control group (P <0.05). Compared with the control group, the added value of MQ in the treatment group was significant (P <0.05). During treatment, the patient did not have serious adverse reactions. Conclusion Ginkgo biloba extract and breviscapine have a synergistic effect, the two combined treatment of stroke sequelae effect is significant, safe and reliable, and can be extended.